A rational screening strategy for thyroid disease in asymptomatic patients with type 1 diabetes should include measurement of TPO-Abs and thyrotropin at diagnosis, followed by annual thyrotropin assessment in antibody-positive individuals. The gene discussed is TPO; the disease is type 1 diabetes mellitus.